UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000024242
Receipt number R000027915
Scientific Title The effect that helped the nonpharmacologic therapy for peripheral neuropathy with the TC therapy
Date of disclosure of the study information 2016/10/01
Last modified on 2016/09/30 18:13:59

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect that helped the nonpharmacologic therapy for peripheral neuropathy with the TC therapy

Acronym

The effect that helped the nonpharmacologic therapy for peripheral neuropathy with the TC therapy

Scientific Title

The effect that helped the nonpharmacologic therapy for peripheral neuropathy with the TC therapy

Scientific Title:Acronym

The effect that helped the nonpharmacologic therapy for peripheral neuropathy with the TC therapy

Region

Japan


Condition

Condition

Lung cancer

Classification by specialty

Nursing

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Our ward is the chemotherapy center, and there are many patients receiving TC therapy. One of the side effects of this treatment has peripheral neuropathy, and, as for most of the treated patient, there is much accusing the pain by the trouble to everyday life due to peripheral neuropathy. Peripheral neuropathy with the chemotherapy greatly influences continuation of quality of life and the treatment of the patient who is not a serious side effect. Improvement of peripheral neuropathy is seen by canceling the dosage of the anticancer agent from an early stage, but there is the characteristic to be easy to be prolonged when I appear once and falls down when a symptom turns worse, and it is thought that the influence on everyday life is big. It is important prevention or that I do not let you increase for peripheral neuropathy to continue, and to cure. Therefore I perform the exercise of hands and feet which are one of the means to soften a symptom and I was effective in not letting you prevent peripheral neuropathy by taking good care or reinforce muscular strength maintenance and the blood circulation of hands and feet or study it.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change of FACT
Change of the grip
Impression of the patient

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Exercise of hands and feet

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

The patient who can perform a nonpharmacologic therapy (exercise of hands and feet) in the selves who are hospitalized, and perform TC therapy

Key exclusion criteria

Unavailable

Target sample size

5


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Akane Harano

Organization

Incorporated administrative agency national hospital mechanism Kyushu medical center

Division name

Chemotherapy center

Zip code


Address

1-8-1, Jigyohama, Chuo-ku, Fukuoka-shi, Fukuoka

TEL

092-852-0700

Email

10eb@qmed.hosp.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Akane Harano

Organization

Incorporated administrative agency national hospital mechanism Kyushu medical center

Division name

Chemotherapy center

Zip code


Address

1-8-1, Jigyohama, Chuo-ku, Fukuoka-shi, Fukuoka

TEL

092-852-0700

Homepage URL


Email

10eb@qmed.hosp.go.jp


Sponsor or person

Institute

Incorporated administrative agency national hospital mechanism Kyushu medical center (clinical study center)

Institute

Department

Personal name



Funding Source

Organization

Unavailable

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2016 Year 09 Month 30 Day

Date of IRB


Anticipated trial start date

2016 Year 11 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 09 Month 30 Day

Last modified on

2016 Year 09 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027915


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name